by Ellen Graves Wojcik, MBA, CCRP, Business Analyst, Winship Cancer Institute at Emory University

Low accrual rates to cancer clinical trials are problematic. For cancer centers, particularly those with or seeking National Cancer Institute (NC) designation, low accruing trials are particularly burdensome. They drain cancer center resources, but more importantly, they potentially waste the efforts of the patients who do enroll on them.

by Lee Doherty, Regulatory Manager, Stanford Cancer Center and Lindsay Mann, CRO Manager and OnCore Administrator, Indiana University Simon Cancer Center

During the “Audits” breakout session at the Onsemble 2010 Spring Conference in February, representatives from the Indiana University Simon Cancer Center and the Stanford Cancer Center shared some of their techniques and processes for managing audits.

Wisconsin’s First Lady Jessica Doyle joined community representatives and Madison Metropolitan School District (MMSD) teachers, administrators, and board members at PercipEnz Technologies on April 13th to challenge businesses to establish e-Cycling policies for computers in support of student learning.

by Yan Carrie Ma, B.Pharm., M.B.A., CCRC, Associate Director of Clinical Research Shared Service, Arizona Cancer Center

Clinical trials are clearly recognized as a significant research component of academic cancer centers. Increased research activities, mounting regulatory requirements, escalating costs and the constraint of funding resources are the important challenges that clinical research professionals face every day. A complex and well-defined clinical research infrastructure is needed.

The OnCore Biospecimen Management workshop is for anyone involved with biobanking at any OnCore center to come together to talk about their processes, needs, what works/what doesn’t, changes happening in the biobanking world, etc.

When the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center decided to enhance their clinical research infrastructure, comprehensive functionality and a reputation for customer service contributed to their decision to select the OnCore clinical research management system from PercipEnz Technologies, Inc. in December.

This year’s release of the OnCore Clinical and Translational Research Software, Version 10.0, represents thousands of hours of development effort and incorporates work done in eight collaborative projects with research organizations around the country.

Onsemble Member has Poster at SAS Global Forum 2010

Onsemble member, Wing-Keung Chiu, a biostatistician at the UNC -  Lineberger Comprehensive Cancer Center, presented a poster at the recent SAS Global Forum.

Available for download at the link below, This poster presents a method to extract data from the Oracle-based OnCore database system using SAS. The necessary SAS code to execute such a procedure is examined in detail. Pros and cons are also discussed. This poster is of interest to any data analysts (SAS programmers, statisticians, etc.) who are interested in the timely and accurate retrieval of important data stored in OnCore. This may be particularly important for data that may not be accessible through the BioStat Console, and therefore must be retrieved from OnCore’s “back end.”

We return to the Fluno Center in Madison, Wisconsin for the August 4-6 event. For more information, click here.

Register Now!